AnalystsRobert HazlettRobert Hazlett's Stock Forecasts
AnalystsRobert Hazlett
Analyst Ranking
Bottom 2%
#4798 out of 4875 analysts
Average Return
-15.06%
Win Rate
34%13 out of 38
Risk vs Reward
Poor
Good
Robert Hazlett's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Kalvista Pharmaceuticals IncKALV | +158.70% | $6.61 | $17.10 | 2017-08-30 - 2018-08-31 | Strong Buy |
Cascadian Therapeutics IncCASC | +144.39% | $4.10 | $10.02 | 2017-04-20 - 2018-03-09 | Strong Buy |
Prothena Corp Public Ltd CoPRTA | +141.53% | $14.35 | $34.66 | 2021-02-01 - 2022-02-01 | Strong Buy |
Cti Biopharma CorpCTIC | +136.91% | $2.98 | $7.06 | 2021-08-08 - 2022-08-08 | Strong Buy |
Zosano Pharma CorpZSANQ | +107.14% | $19.60 | $40.60 | 2020-03-26 - 2021-03-26 | Strong Buy |
Robert Hazlett Analyst Color
Get additional color on Robert Hazlett's coverage of popular stocks
Robert Hazlett's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aura Biosciences IncAURA | 3 | Strong Buy | $24.00 | +348.60% | Maintains | 7 months ago |
Nektar TherapeuticsNKTR | 2 | Strong Buy | $4.00 | +459.44% | Assumes | 7 months ago |
Rani Therapeutics Holdings IncRANI | 2 | Strong Buy | $14.00 | N/A | Maintains | a year ago |
Seelos Therapeutics IncSEELQ | 5 | Strong Buy | $15,360.00 | N/A | Maintains | 2 years ago |
Lyra Therapeutics IncLYRA | 1 | Strong Buy | $20.00 | N/A | Maintains | 2 years ago |
Axsome Therapeutics IncAXSM | 2 | Strong Buy | $98.00 | N/A | Maintains | 2 years ago |
Verastem IncVSTM | 3 | Strong Buy | $60.00 | N/A | Maintains | 3 years ago |
Eiger Biopharmaceuticals IncEIGRQ | 1 | Strong Buy | $1,440.00 | N/A | Maintains | 3 years ago |
Q32 Bio IncQTTB | 3 | Strong Buy | $216.00 | N/A | Maintains | 3 years ago |
Zosano Pharma CorpZSANQ | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Galera Therapeutics IncGRTX | 2 | Strong Buy | $15.00 | N/A | Upgrades | 3 years ago |
Cti Biopharma CorpCTIC | 1 | Strong Buy | $7.00 | N/A | Initiates Coverage On | 4 years ago |
Compass Pathways PLCCMPS | 1 | Strong Buy | $63.00 | N/A | Initiates Coverage On | 4 years ago |
Tracon Pharmaceuticals IncTCON | 2 | Strong Buy | $280.00 | N/A | Upgrades | 4 years ago |
Aravive IncARAV | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 4 years ago |
Prothena Corp Public Ltd CoPRTA | 4 | Strong Buy | $29.00 | N/A | Upgrades | 4 years ago |
Intra Cellular Therapies IncITCI | 1 | Strong Buy | $40.00 | N/A | Maintains | 5 years ago |
Redhill Biopharma LtdRDHL | 1 | Strong Buy | $26,000.00 | N/A | Initiates Coverage On | 5 years ago |
Akebia Therapeutics IncAKBA | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 7 years ago |
Kalvista Pharmaceuticals IncKALV | 2 | Strong Buy | $27.00 | N/A | Maintains | 8 years ago |
Clementia Pharmaceuticals IncCMTA | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 8 years ago |
Cascadian Therapeutics IncCASC | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.